HIV/HCV Co-infection: An AETC National Curriculum
The goal of this curriculum is to provide an evidence-based online curriculum for healthcare providers and trainers of healthcare providers to increase their knowledge on human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infection among people of color in the United States and its territories Topics covered include prevention, screening, diagnosis and treatment recommendations as well as barriers and other co-factors that may impede optimal treatment outcomes for co-infected people of color.
Access the curriculum HERE
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
This exciting grassroots initiative will tap into the strengths and resources of communities in inner-city and metropolitan areas to provide effective therapy for hepatitis C virus (HCV)-positive people who inject drugs (PWIDs). Live meetings for small, community-based groups of healthcare professionals will offer medical and addiction-services specialists cutting-edge strategies to collaboratively reach and treat HCV-positive PWIDs. Balancing clinical data with real-world experience and insights, these educational events will give participants the opportunity to interact directly with HCV and harm-reduction experts as well as resources to use and share in the practice setting. Strong local HCV-care networks will help build bridges to HCV-infected PWIDs and allow these high-risk individuals access to the care they need and deserve.
Access the training HERE
Visit The Clinical Consultation Center:
We consult on HCV management topics, including:
- HCV staging & monitoring
- Regimen selection & dosing
- Drug interactions
- HIV/HCV management strategies
- Prior HCV treatment failure, including management of complex clinical problems such as cirrhosis and renal disease
- HCV transmission & prevention
- HCV screening & diagnostic testing
- HCV in special populations (pregnancy, co-occurring substance use and/or alcohol use disorders, psychiatric disorders, post-transplant, ESRD/dialysis, pediatrics)
Our clinical consultation staff stays abreast of the latest hepatitis C drug regimens and treatment guidelines in a rapidly evolving care environment to ensure the advice you receive is up-to-date and clinically supported.
Advice for providers from national experts
The CCC’s consultation on HIV/AIDS and exposure management has helped guide clinicians for more than 25 years. That same expert consultation is now available for decision-making around hepatitis C mono-infection management, including regimen selection and dosing, co-morbidities, toxicity and complications, and special populations.
Rapid, confidential answers for your hepatitis C care questions
Our clinicians are available Monday through Friday, 9:00 a.m. to 5:00 p.m. EST. Voice mail and online case submission are available 24 hours a day. We answer your questions as immediately as possible. Most are answered within two hours.
*Cover Photo by HepCAP member Ginny Robison, Philadelphia Health Department: Shi.Robison@Phila.gov*